Carcinoma, Neuroendocrine
"Carcinoma, Neuroendocrine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)
| Descriptor ID |
D018278
|
| MeSH Number(s) |
C04.557.465.625.650.240 C04.557.470.200.025.370 C04.557.580.625.650.240
|
| Concept/Terms |
Carcinoma, Neuroendocrine- Carcinoma, Neuroendocrine
- Carcinomas, Neuroendocrine
- Neuroendocrine Carcinoma
- Neuroendocrine Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Neuroendocrine".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Neuroendocrine".
This graph shows the total number of publications written about "Carcinoma, Neuroendocrine" by people in this website by year, and whether "Carcinoma, Neuroendocrine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 4 | 0 | 4 |
| 2013 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Neuroendocrine" by people in Profiles.
-
Metastatic Eyelid Lesion of High-Grade Neuroendocrine Carcinoma From Parotid Gland Primary. JAMA Ophthalmol. 2023 07 01; 141(7):e231005.
-
Metastatic Risk Stratification of 2526 Medullary Thyroid Carcinoma Patients: A Study Based on Surveillance, Epidemiology, and End Results Database. Endocr Pathol. 2022 Sep; 33(3):348-358.
-
Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix. Appl Immunohistochem Mol Morphol. 2021 04 01; 29(4):299-304.
-
Serotonin Pathway in Cancer. Int J Mol Sci. 2021 Jan 28; 22(3).
-
Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis. Head Neck. 2019 08; 41(8):2823-2829.
-
Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast. Clin Breast Cancer. 2019 04; 19(2):131-136.
-
Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis. Endocr Relat Cancer. 2018 06; 25(6):633-641.
-
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions. Oncologist. 2017 03; 22(3):255-263.
-
Clinicopathologic predictors of thyroid bed recurrence of differentiated thyroid cancer using ultrasound-guided fine-needle aspiration biopsies. Thyroid. 2013 Aug; 23(8):982-8.
-
Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol. 2012 Nov; 36(11):1666-73.